OTCM
WLMIY
Market cap17bUSD
Jun 18, Last price
28.01USD
1D
0.54%
1Q
-4.50%
Jan 2017
13.82%
IPO
34.99%
Name
Wilmar International Ltd
Chart & Performance
P/E
149.48
P/S
2.60
EPS
0.19
Div Yield, %
3.87%
Shrs. gr., 5y
57.95%
Rev. gr., 5y
9.58%
Revenues
67.38b
+0.33%
Net income
1.17b
-23.28%
CFO
1.37b
-64.69%
Dividend
Aug 22, 20250.31102 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in 1991 and based in Singapore, Wilmar International Limited is a prominent global agribusiness conglomerate. Its extensive operations span multiple continents, including Southeast Asia, China, India, Europe, Australia/New Zealand, and Africa. The company's business activities are categorized into four key segments. The Food Products division is responsible for the processing, branding, and distribution of a wide array of edible goods, such as vegetable oils derived from palm and oilseeds, sugar, flour, rice, noodles, specialty fats, snacks, and dairy products. The Feed and Industrial Products segment focuses on the production, marketing, and distribution of items like animal feeds, non-edible palm and lauric products, agricultural commodities, oleochemicals, gas oil, and biodiesel. Through its Plantation and Sugar Milling segment, Wilmar engages in the cultivation and processing of both palm oil and sugarcane. The "Others" segment encompasses logistics and jetty port services. As of December 31, 2021, Wilmar owned substantial oil palm plantations covering 230,480 hectares across Indonesia, Malaysia, and Africa. The company operated under the name Ezyhealth Asia Pacific Ltd before officially becoming Wilmar International Limited in July 2006.
IPO date
Aug 08, 2006
Employees
100,000
Domiciled in
SG
Incorporated in
SG
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||